ZEB2 and breast carcinoma: Cluster 5 is enriched in lung carcinoma and breast cancer samples with a general high activity of ZEB2, a promoter of epithelial to mesenchymal transition (EMT), metastasis and resistance in LUAD and breast cancer (Zhang et al, 2015; Malvi et al, 2019).